Functional parameters but not heart rate variability correlate with long-term outcomes in St-elevation myocardial

Leonida Compostella1, Nenad Lakusic2, Nicola Russo1

  • 1Preventive Cardiology and Rehabilitation, Inst. Codivilla-Putti, Cortina d'Ampezzo (BL), Italy; Dpt Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy.

Insights

Heart rate variability (HRV) no longer predicts outcomes after ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI). Left ventricular ejection fraction and physical performance are better prognostic indicators in these patients.

Area of Science:

  • Cardiology
  • Clinical Research
  • Medical Prognostics

Background:

  • Depressed heart rate variability (HRV) traditionally indicates poor prognosis post-myocardial infarction.
  • Previous studies predated current reperfusion therapies like percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To determine if HRV retains prognostic value after acute myocardial infarction (STEMI) in the era of primary PCI.
  • To compare the prognostic significance of HRV with other clinical parameters.

Main Methods:

  • Assessed time-domain HRV using 24-h Holter recordings in 186 STEMI patients post-primary PCI.
  • Evaluated physical performance via 6-minute walk tests (6MWT) and cardiopulmonary exercise testing (CPET).
  • Monitored major clinical events (MCE) over a >2-year follow-up period.

Main Results:

  • Markedly depressed HRV was observed in a small percentage of patients (16% with SDNN <70ms, 5% with SDNN <50ms).
  • No significant difference in MCE or survival was found based on initial HRV parameters.
  • Poorer outcomes correlated with reduced left ventricular ejection fraction (LVEF <40%), shorter 6MWT distances, and lower CPET ventilatory efficiency.

Conclusions:

  • HRV appears to have lost its prognostic significance in STEMI patients treated with primary PCI.
  • Left ventricular ejection fraction and physical performance metrics offer superior prognostication in this patient cohort.
Abstract